Related Experiment Videos
Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis
W E Samlowski1, C Y Yim, J R McGregor
1Cancer Immunotherapy Program, Huntsman Cancer Institute, Salt Lake City, Utah, USA. wolfs@crc-gw.med.utah.edu
Abstract:
Nitric oxide synthesis is strongly induced during IL-2 treatment of mice and humans. While this free radical can act as an antitumor mechanism by inhibiting cellular respiration and DNA synthesis in cancer cells, immunosuppressive effects have also been suggested. We evaluated the effects of NO exposure on the induction of murine lymphokine-activated killer (LAK) cells from splenocytes by IL-2 (6000 IU/ml). When splenocytes were exposed to pure NO gas for 30 min prior to the addition of IL-2, complete abrogation of LAK cell cytotoxicity was observed. In contrast, cytolytic activity of already activated LAK cells was only minimally affected by NO exposure. NO exposure markedly depressed cellular proliferation in response to concanavalin A or IL-2. Immunostaining of LAK cell cultures following NO exposure revealed a marked decrease in CD8+, and peanut lectin (PNA+)/CD56+ subsets (48 and 69%). Dual staining of LAK cells for DNA strand breaks and either PNA or CD8+ identified the induction of programmed cell death in these subsets 12-24 h following NO exposure. These experiments demonstrate that NO has the capacity to inhibit LAK cell induction by inducing apoptosis of cytolytic lymphocyte precursors.
Insights
Nitric oxide (NO) inhibits the development of lymphokine-activated killer (LAK) cells by inducing programmed cell death in lymphocyte precursors. This finding suggests NO may suppress anti-tumor immunity during IL-2 therapy.
Area of Science:
- Immunology
- Cell Biology
- Cancer Research
Background:
- Interleukin-2 (IL-2) therapy induces nitric oxide (NO) synthesis.
- NO can have anti-tumor effects but also potential immunosuppressive roles.
Purpose of the Study:
- To investigate the impact of NO exposure on the induction of murine lymphokine-activated killer (LAK) cells.
- To determine if NO affects LAK cell cytotoxicity, proliferation, or survival.
Main Methods:
- Splenocytes were exposed to NO gas before IL-2 stimulation.
- LAK cell cytotoxicity, proliferation (concanavalin A or IL-2), and subset populations (CD8+, PNA+/CD56+) were assessed.
- Apoptosis was detected using DNA strand break staining.
Main Results:
- Pre-treatment with NO completely abrogated LAK cell induction.
- NO exposure minimally affected established LAK cell cytotoxicity but reduced proliferation.
- NO induced apoptosis in CD8+ and PNA+/CD56+ lymphocyte precursors.
Conclusions:
- NO inhibits LAK cell induction by triggering apoptosis in precursor cells.
- NO exposure can impair the development of crucial anti-tumor immune cells.